TGFBR2 and amyotrophic lateral sclerosis: We recently could show that, compared to healthy controls, TGFβ and its receptor TGFBR2 are upregulated in post mortem CNS tissue of ALS patients, with subsequent decreased stem cell activities in brain and SC [1].